Contingency Management Treatment Duration

Alcohol Abuse Clinical Trial

— Duration  

Official title:

Contingency Management Treatment Duration

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00732342
• Other study ID #: 08-053-2
• Secondary ID: P60AA003510
• Status: Completed
• Phase: N/A
• Start date: February 2008
• Est. completion date: May 2015

Study information

• Verified date: April 2019
• Source: UConn Health
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

310 alcohol abusing or dependent patients beginning intensive outpatient day treatment at community-based clinics will be randomly assigned to one of four conditions: (a) standard treatment as usual (ST) at the clinic without contingency management (CM); (b) standard treatment with contingency management for 12 weeks with a 0.5 probability of winning prizes for each negative sample submitted; (c) standard treatment with contingency management for 24 weeks with a 0.34 probability of winning prizes for each negative sample submitted; or (d) standard treatment with contingency management for 24 weeks with a 0.5 probability of winning prizes for each negative sample submitted. We expect that contingency management will decrease alcohol use to a greater extent than non-contingency management treatment, and that availability of contingency management for 24 weeks may result in longer term benefits than 12 week exposure to contingency management. This study will be the first to evaluate the effects of probability of winning prizes on response to contingency management.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 310
• Est. completion date: May 2015
• Est. primary completion date: May 2015
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• age > 18 years

• current DSM-IV diagnosis of alcohol abuse or dependence

• willing to sign informed consent and able to pass an informed consent quiz

Exclusion Criteria:

• serious, uncontrolled psychiatric illness (e.g., acute schizophrenia, bipolar disorder, severe or psychotic major depression, or suicide risk) on the basis of history or medical examination

• current DSM-IV diagnosis of opioid dependence

• in recovery from pathological gambling

Related Conditions & MeSH terms

• Alcohol Abuse
• Alcoholism

Intervention

Behavioral:
• Contingency Management
Prizes given for targeted behavior of abstinence

Locations

Country	Name	City	State
United States	Prospect House	Bridgeport	Connecticut
United States	Alcohol and Drug Recovery Centers, Inc.	Hartford	Connecticut
United States	The Hospital of Central Connecticut at New Britain General	New Britain	Connecticut
United States	Carlson Recovery Center	Springfield	Massachusetts
United States	Morris Foundation	Waterbury	Connecticut

Sponsors (2)

Lead Sponsor	Collaborator
UConn Health	National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	longest duration of negative breath samples submitted		active phase and throughout follow-up phase
Secondary	subjective reports of alcohol use		baseline and each follow-up